A Clinical Trial Comparing Efficacy And Safety Of Sunitinib And Capecitabine
Status:
Terminated
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
To compare efficacy and safety of Sunitinib and Capecitabine in subjects with advanced breast
cancer who failed both a taxane and an anthracycline chemotherapy regimen or failed with a
taxane and for whom further anthracycline therapy is not indicated